Adams Share Price (ADA)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Adams Plc	LSE:ADA	London	Ordinary Share	IM00B986V543	ORD GBP0.01

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	8.00	0.00	08:00:09

Bid Price		Offer Price	High Price	Low Price	Open Price
7.00		9.00	8.00	7.40	8.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Real Estate Investment & Services		-0.27	-0.33		12

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
-	O	0	8.00	GBX

Related Shares
Unite (UTG), Grainger (GRI), Pathfinder Minerals (PFP), Mena Land (MENA)

Adams (ADA) Latest News

Adams News

Date	Time	Source	Headline
07/5/2021	17:51	ALNC	IN BRIEF: Adams buys 8 million shares in Seeing Machines
07/5/2021	11:33	UKREG	Adams PLC Holding(s) in Company
07/5/2021	11:30	UKREG	Adams PLC Holding(s) in Company
07/5/2021	07:00	UKREG	Adams PLC Investment in Seeing Machines Limited
15/4/2021	12:48	UKREG	Adams PLC Result of Open Offer
26/3/2021	14:36	ALNC	TRADING UPDATES: Renew to buy J Browne; Idox in good start to year
26/3/2021	07:00	UKREG	Adams PLC Placing and Open Offer
26/11/2020	16:34	ALNC	UK EARNINGS SUMMARY: MySale Loss Narrows, Sees Good Start To New Year
26/11/2020	07:00	UKREG	Adams PLC Half-year Report
22/10/2020	20:33	ALNC	IN BRIEF: Adams Invests GBP700,000 In C4X Discovery's Fund Raise

More Adams News

Adams Investors Adams Takeover Rumours

Adams (ADA) Share Charts 1 Year Adams Chart
1 Month Adams Chart	Intraday Adams Chart

Adams (ADA) Discussions and Chat

Adams Forums and Chat

Date	Time	Title	Posts
03/2/2021	09:27	Adams - The Start of Something New	90
17/6/2020	06:08	adams	46
15/9/2011	20:15	Time to add Adalta Real	65
25/6/2011	10:49	Adamind 2007	1,118
16/11/2008	18:15	Adamind trading at less than cash	798

Add a New Thread

Adams (ADA) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Adams trades in real-time

Adams (ADA) Top Chat Posts

Date	Subject
11/5/2021 09:20	Adams Daily Update: Adams Plc is listed in the Real Estate Investment & Services sector of the London Stock Exchange with ticker ADA. The last closing price for Adams was 8p. Adams Plc has a 4 week average price of 7.40p and a 12 week average price of 7.40p. The 1 year high share price is 32.50p while the 1 year low share price is currently 5p. There are currently 145,859,231 shares in issue and the average daily traded volume is 17,012 shares. The market capitalisation of Adams Plc is £11,668,738.48. Read Full Thread Reply
03/2/2021 09:27	skyship: Resist the temptation to follow into ADA on the current rise to 8p. The rise may well be because of the great performance of their recently acquired holding in C4XD, which gives them a carried paper profit of c£1million. However - look under the bonnet at their other holdings and their performance since the 30th Sept'20 Interims: # CIR - largest holding - N/C # DNL - N/C # DDDD - Down 30% # TALK - Up 20% # GFM - Up 130% - but represents a value increase of just £170k # SBI - Up 50% - but represents a value increase of just £70k At 8p the MCap = £6.6m - not the £3.3m shown on the Quote page! There are 82.55m shares in issue. My estimated current NAV of £5m = 6.0p/share Don't pay a premium for an investment company - especially one controlled as to 77.3% by Richard Griffiths. Perhaps consider a similarly sized investment company on a 40%+ discount & with a current MCap of £5.5m. PRIM @ 4p is backed by 3.5p in cash and another 3.5p in a portfolio of unlisted investments. Looks like a better bet. I declare a holding. Read Full Thread Follow Reply
22/10/2020 15:51	the stigologist: https://www.investegate.co.uk/adams-plc--ada-/rns/investment-commitment-in-c4x-discovery-holdings/202010221023339241C/ Read Full Thread Follow Reply
10/6/2020 07:35	vega44: Investment in Oxehealth Limited ("Oxehealth") The Directors announce that, on 9 June 2020, Adams committed to subscribe for 21,630 new ordinary shares of £0.001 in Oxehealth at a price of £26.19 per share for a total cash consideration of £566,489.70 under a subscription agreement dated today ("Subscription Agreement"), which will raise gross subscription proceeds of £5 million for Oxehealth. Settlement of the cash consideration will be by way of payment of £339,893.82 on the first completion date of on or around 10 June 2020, followed by payment of £226,595.88 on the second final completion date of on or around 10 November 2020. The Company's total holding of 21,630 ordinary shares of £0.001 in Oxehealth following the second final completion will represent 2.4% of the issued ordinary share capital of Oxehealth of 903,083 shares at that date. Adams is expected to have remaining cash balances of approximately £240,000 following this investment. Richard Griffiths, who has an interest in 77.3% of Adams' issued share capital, has a current interest in 144,182 Oxehealth shares representing approximately 20.33% of Oxehealth's issued share capital, and Michael Bretherton, Chairman of Adams, holds 1,310 shares in Oxehealth representing 0.18% of its issued share capital. Richard Griffiths is subscribing for 15,274 new ordinary shares in Oxehealth under the Subscription Agreement for a consideration of £400,026 through his controlled undertaking, ORA Limited, and Mr Bretherton is subscribing for 1,528 new ordinary shares in Oxehealth under the Subscription Agreement for a consideration of £40,018. Following full completion of the Subscription Agreement, Mr Griffiths will have a total interest in 181,086 Oxehealth shares, including the Oxehealth shares held by Adams, representing 20.06% of Oxehealth's enlarged share capital. Other substantial shareholders in Oxehealth include the IP Group plc, which is also investing in the current funding round in order to maintain their interest of approximately 35% in Oxehealth's issued share capital held directly and through the IP Venture Fund II. As a result of Michael Bretherton's personal interest in Oxehealth and his directorship of ORA Limited, he took no part in the Board's decision to invest in Oxehealth. About Oxehealth Oxehealth is involved in vision-based patient monitoring and management, using proprietary signal processing and computer vision to process normal digital video camera data to measure the vital signs and activity of patients. This is achieved through the deployment of their Digital Care Assistant (DCA) platform which consists of a fixed installation camera and illuminator, monitoring screens and software modules including the Vital Signs module, a Class IIa medical device cleared in Europe which represents a global first for a software. The platform enables clinicians to take non-contact cardiorespiratory measurements of patients' pulse and breathing rate, generates alerts to potentially risky activity and reports on patients' vital signs and behaviour, all without the clinician entering the patient's room. The system offers measurable benefits in helping clinicians to improve the safety of both patients and carers. Since its commercialisation in 2018, the DCA been deployed into a number of different markets, primarily in Mental Health, Acute Hospital settings, Primary Care settings, Care Home, and Custodial facilities in both the UK and now in Sweden. Since launch, the DCA has achieved significant traction, being deployed in 30% of all NHS England Mental Health Trusts. These partners have seen improvements in safety, quality and efficiency, with recent data* demonstrating: · 48% reduction in falls in dementia facility · 68% reduction in A&E visits from the dementia facility · 49% reduction in emergency service visits · 71% reduction in spend on enhanced observations Recently, Oxehealth has reported that clinicians have made increasing use of the Oxehealth Service when caring for patients with COVID-19, both in Mental Health and also in Primary Care settings (General Practitioner COVID-19 Triage Hubs), due to its ability to limit clinician to patient contact whilst helping to maintain patient safety remotely. With non-contact monitoring becoming increasingly important and clinically relevant, Oxehealth plans to further expand into Europe and North America. The last filed accounts for Oxehealth are for the year ended 31 December 2018 and include a loss after tax of approximately £2.8 million, reflecting the continued significant investment in development and marketing in that year. Barney Quinn, Chairman of Oxehealth, commented: "We would like to thank Adams Plc for contributing to the current successful funding round. The investment shows the faith in the Oxehealth Digital Care Assistant and the measurable benefits it brings to patients, clinicians and managing healthcare budgets. The investment funds will help Oxehealth on its continued expansion in the UK and internationally." Further information on Oxehealth is available on the Oxehealth website www.oxehealth.com. Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement. *Source data published in early 2020 by Coventry & Warwickshire Partnership NHS Trust with support from Oxehealth following an 8 month clinical study on the impact of using the Digital Care Assistant (DCA) on their dementia wards. Read Full Thread Follow Reply
20/9/2015 16:35	hedgehog 100: 18/09/2015 07:00 UKREG Adams PLC Issue of Equity " ... The Company is pleased to announce that its broker, Peterhouse Corporate Finance Limited, has co-ordinated a conditional placing of 18,181,818 new ordinary shares of EUR0.01 each ("Placing Shares"), representing 44 per cent. of the enlarged issued share capital of the Company, with new and existing investors at a placing price of 4.4p per ordinary share to raise GBP800,000 for the Company before expenses (the "Placing"). The proceeds of the Placing will be used make investments in accordance with the Company's investing policy and for general working capital purposes. ... Application has been made for the 18,181,818 new ordinary shares to be admitted to trading on AIM. Admission is expected to occur on or around 23 September 2015. ... For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following the placing will be 41,276,616 ordinary shares. ..." http://uk.advfn.com/news/UKREG/2015/article/68561865 Glavey, You're being too generous. The placing at 4.4p was actually a 63.33% discount to the pre-existing share price of 12p. Strange that the price rose on Friday: Price Price Change [%] Bid Offer Open High Low Volume 0.15 0.025 [20.83] 0.12 0.17 0.11 0.15 0.11 12,586 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range 3.35 23.09 3.19 -0.10 - - - 0.23 - 0.11 The new market cap. at the current price would be about £6M. Read Full Thread Follow Reply
20/9/2015 03:06	glavey: Issue of Equity. Really wonderful how all these related party transactions are just passed off as fair and reasonable at a 50% discount to current share price when it represents a near 80% dilution for those not invited to participate. Last year they flogged off a few assets and gave themselves a bung to mop up the returns. If they want to run it as a private fiefdom why not make an offer to buy out the other shareholders. Read Full Thread Follow Reply
22/1/2015 18:06	rbcrbc: http://www.investegate.co.uk/adams-plc--ada-/rns/holding-s--in-company/201501221503329196C/ Mr David H Richardson increasing his stake through 15-23% today but no price change - is something about to happen ? Read Full Thread Follow Reply
17/9/2014 10:09	skier100: ADA is a 6-bagger in 2 hours today. Well done to all the investors with quick fingers who made money here today. Well done to all the ADA investors who ignored the derampers in the past few days. With a new investment on the way, a famous big investor onboard with a 28% stake (Richard Griffiths), and a tiny 8m free-float of shares, ADA is undergoing a major rerating. Read Full Thread Follow Reply
16/9/2014 22:14	skier100: ADA's shareprice 6-bagged between Mar 2013 and Oct 2013 in anticipation of ADA spending its new funds and backing in a new investment. ADA, right now, in Sep 2014, is once again at the point in its cycle where it has new funds coming in, a famous investor with a 28% stake, and the Board is discussing a new investment. New money + new investment + new news = rerating for ADA... Read Full Thread Follow Reply
16/9/2014 16:38	skier100: Praipus -- Take a look at the 3 funding RNSs ADA released in Sep 2014. ADA is sitting on far more cash now than this time last year. The Board is also looking at a new investment to back into ADA. And as you rightly pointed out, Richard Griffiths and Ora Capital Partners now have a 28% stake in ADA. Such a famous investor would not take such a big stake in ADA if he didn't think / know something was cookin' here. Read Full Thread Follow Reply
16/9/2014 14:58	skier100: ADA is now ready for takeoff. Presently offering a tiny marcap under £1m, ADA is sitting on spare cash and reviewing currently a new investment to back into (RTO into a shell). ADA has a miniscule free float of just 8 million shares on AIM. Once ADA moves, it will move fast. Investors will be aware that EMT 50-bagged and CHA 10-bagged in anticipation of new shell investments this year. Read Full Thread Follow Reply

Adams share price data is direct from the London Stock Exchange

Advertise Here

Your Recent History

LSE

ADA

Adams

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20210512 03:14:32